ZA836349B - Production of antibodies - Google Patents

Production of antibodies

Info

Publication number
ZA836349B
ZA836349B ZA836349A ZA836349A ZA836349B ZA 836349 B ZA836349 B ZA 836349B ZA 836349 A ZA836349 A ZA 836349A ZA 836349 A ZA836349 A ZA 836349A ZA 836349 B ZA836349 B ZA 836349B
Authority
ZA
South Africa
Prior art keywords
antibodies
mammal
production
vaccine
hyperimmunising
Prior art date
Application number
ZA836349A
Other languages
English (en)
Inventor
Margaret Anneli Linggood
Philip Porter
Jonathan Richard Powell
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of ZA836349B publication Critical patent/ZA836349B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA836349A 1982-09-02 1983-08-26 Production of antibodies ZA836349B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225036 1982-09-02

Publications (1)

Publication Number Publication Date
ZA836349B true ZA836349B (en) 1985-04-24

Family

ID=10532644

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA836349A ZA836349B (en) 1982-09-02 1983-08-26 Production of antibodies

Country Status (12)

Country Link
EP (1) EP0102831B1 (da)
JP (2) JPS5973528A (da)
AT (1) ATE43500T1 (da)
AU (1) AU548623B2 (da)
CA (1) CA1219806A (da)
DE (1) DE3379937D1 (da)
DK (1) DK398683A (da)
GB (1) GB2126236B (da)
HK (1) HK91087A (da)
IE (1) IE55673B1 (da)
NZ (1) NZ205392A (da)
ZA (1) ZA836349B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
JPS6399020A (ja) * 1986-06-05 1988-04-30 ベイラ−　カレツジ　オブ　メデイシン ワクチンとその製法
US4725435A (en) * 1986-06-18 1988-02-16 Bactex, Inc. Vaccine composition for immunization against urinary tract infection caused by E. coli
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
AU601510B2 (en) * 1987-11-06 1990-09-13 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
DE4026365A1 (de) * 1990-08-21 1992-02-27 Biotest Pharma Gmbh Sterilfiltrierte kolostralmilch
EP0725789B1 (en) * 1993-09-20 2003-03-19 Anadis Ltd. Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
ES2076895B1 (es) * 1994-02-04 1996-08-16 Ind Farma Especial Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.
US6471966B1 (en) 1994-02-04 2002-10-29 Industrial Farmaceutica Y De Especialidades, S.A. Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
US5670196A (en) * 1995-04-12 1997-09-23 Galagen Inc. Method for microfiltration of milk or colostral whey
DE19641466A1 (de) * 1996-10-09 1998-04-16 Biotest Pharma Gmbh Orale Anwendung eines Immunglobulinpräparates zur Prävention des Hämolytischen Urämischen Syndroms sowie Präparat hierfür
US7785778B2 (en) 2002-11-25 2010-08-31 University Of Copenhagen Porcine polymorphisms and methods for detecting them
AU2003901008A0 (en) * 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
JPS5842759B2 (ja) * 1975-05-23 1983-09-21 カブシキガイシヤ バイオリサ−チセンタ− セルラ−ゼノセイゾウホウ
GB1553664A (en) * 1975-06-12 1979-09-26 Unilever Ltd Antigenic compositions
JPS52120116A (en) * 1976-04-02 1977-10-08 Kitasato Inst Domestic animal colitis germ inactevated vaccine
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
JPS5781417A (en) * 1980-09-15 1982-05-21 Bactex Inc Human immunity effect imparting vaccine against escherichia coli infectious desease
DE3172030D1 (en) * 1980-09-15 1985-10-03 Bactex Inc Immunization of humans against enterotoxogenic infection by escherichia coli
JPS5784147A (en) * 1980-11-13 1982-05-26 Seiko Epson Corp Manufacture of integrated circuit

Also Published As

Publication number Publication date
DE3379937D1 (en) 1989-07-06
ATE43500T1 (de) 1989-06-15
DK398683D0 (da) 1983-09-01
AU1853883A (en) 1984-03-08
EP0102831B1 (en) 1989-05-31
CA1219806A (en) 1987-03-31
HK91087A (en) 1987-12-11
DK398683A (da) 1984-03-03
IE832055L (en) 1984-03-02
NZ205392A (en) 1987-03-06
AU548623B2 (en) 1985-12-19
IE55673B1 (en) 1990-12-19
GB8323455D0 (en) 1983-10-05
GB2126236A (en) 1984-03-21
EP0102831A1 (en) 1984-03-14
JPS5973528A (ja) 1984-04-25
GB2126236B (en) 1986-09-24
JPH02160726A (ja) 1990-06-20

Similar Documents

Publication Publication Date Title
DE3379937D1 (en) Production of antibodies
EP0077734A3 (en) Production of monoclonal antibodies against bacterial adhesins
ATE7201T1 (de) Verfahren zur herstellung eines bakteriellen praeparates zur verhuetung von darmbeschwerden beim gefluegel.
DE69529219D1 (en) Helicobacter proteine und impstoffe
GR3005768T3 (da)
CA2022420A1 (en) Escherichia coli vaccine
EP0299183A3 (en) Method for increasing the protein contents of milk in ruminants
NZ212244A (en) Preparation of cell surface protein of fibronectin binding properties useful as topical anti-infectant and vaccine
FI834724A7 (fi) Maitotuotteiden käsittely maitohappobakteereilla ja laktoosia hajottavilla entsyymeillä ja näin saatujen tuotteiden käyttö ravintoaineiden valmistuksessa.
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
DE2964176D1 (en) Heteropolysaccharides produced by bacteria and derived products, their preparation, and the lyophilized culture of the bacteria
ATE112320T1 (de) Sekretormutante von escherichia coli.
DE3686158D1 (de) Impfstoff gegen mastitis.
AU575544B2 (en) Derived nisin producing microorganisms
NZ238596A (en) Preparation of transparent milk whey protein by heating solution below ph 4 or above ph 6
NO900992L (no) Fremgangsmaate for fremstilling av en drikk med en ph-verdi av 3,6 til 4,2 og paa basis av usyrnet melk.
DK145988A (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
EP0084522A3 (de) Neue Plasmide und Bakterienstämme sowie Verfahren zu ihrer Herstellung
AU3835385A (en) Vaccine for humans and warm-blooded animals
Uradzinski et al. The influence of heating on the survival of Salmonella sp. in naturally souring milk.
Vitkov et al. Antigenic structural studies of S. aureus strains in mastitis in cows
IT9047536A0 (it) Ceppo di batteri lactobacillus casei subsp. casei 37 per la produzione di un preparato biologico batteriale.
Varadaraj Incidences of staphylococci in milk and milk products marketed in India.
Geringer Investigations on the presence of pathogenic and enterotoxigenic staphylococci in goat milk.
CA2347278A1 (en) Vaccine based on attenuated haemophilus somnus